Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chronic Kidney Disease
Clinical trial register · United States · industry-sponsored

Chronic Kidney Disease Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9183 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 01 Nov 2026, 03:16 UTC
9183
Studies in scope
industry-sponsored, all four open statuses
4981
Recruiting now
open to new participants
2200
Lead sponsors
across recruiting studies
Top states
California 11 Florida 9 Alabama 4 Georgia 4 Illinois 4
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Chronic Kidney Disease trials in the USA

15 of 9183 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
AstraZeneca
Phase 3
7,000
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia
2026-08-21
Recruiting
Renal Impairment Study for Oral EC5026
NCT07694544Chronic Kidney Disease
DrugEC5026
EicOsis Human Health Inc.
Phase 1
18
California
2026-07-01
Active, closed
Boehringer Ingelheim
Phase 3
135
Alabama, California, Florida, Georgia, Illinois, Indiana, Kentucky, Maryland
2025-12-09
Recruiting
Novartis Pharmaceuticals
Phase 1
112
Florida
2025-11-20
Recruiting
Ingenia Therapeutics INC
Phase 1/2
94
California, Florida, North Carolina
2025-10-30
Recruiting
Pivotal Study of the Velocity™ pAVF System
NCT07153939Chronic Kidney Disease, Hemodialysis Access, Arteriovenous Fistula, End Stage Renal Disease (ESRD)
Venova Medical
Not applicable
126
Alabama, California, Florida, New York, North Carolina, South Carolina, Texas
2025-10-21
Recruiting
Novo Nordisk A/S
Phase 2
465
California, Colorado, Florida, Illinois, Indiana, Michigan, Missouri, New York
2024-12-02
Recruiting
Scaled Insights
Observational
3,000
Texas
2024-09-01
Recruiting
Bayer
Observational
50,000
New Jersey
2024-05-15
By invitation
Prokidney
Observational
50
Idaho
2023-11-23
Recruiting
Bayer
Phase 3
100
Arizona, California, District of Columbia, Florida, Georgia, Iowa, Maryland, Massachusetts
2022-11-08
Active, closed
Bayer
Observational
4,613
Alabama, Arizona, Arkansas, California, Florida, Georgia, Hawaii, Illinois
2022-06-13
Recruiting
Amgen
Phase 3
56
California, Colorado, Missouri, New York, Ohio, Oklahoma, Pennsylvania, Texas
2019-04-29
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 1 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/chronic-kidney-disease

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,183 studies in total at the last sync on 01 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Chronic Kidney Disease.

How many Chronic Kidney Disease trials are recruiting in the US?

11 of the 15 studies on this page are recruiting new participants as of the 01 Nov 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chronic Kidney Disease), 15 studies
PhaseStudiesRecruitingShare
Phase 35333.3%
Observational4226.7%
Phase 13320%
Not applicable116.7%
Phase 1/2116.7%
Phase 2116.7%

Most active sponsors

Lead sponsors with the most studies (Chronic Kidney Disease)
Lead sponsorStudiesRecruiting
Bayer42
AstraZeneca22
Amgen11
Boehringer Ingelheim10
EicOsis Human Health Inc.11
Ingenia Therapeutics INC11
Novartis Pharmaceuticals11
Novo Nordisk A/S11
Prokidney10
Scaled Insights11

Top states

Top states (Chronic Kidney Disease), by number of studies with a site there
StateStudies
California11
Florida9
Alabama4
Georgia4
Illinois4
Texas4
Arizona3
Colorado3
Maryland3
Missouri3
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.